Although hyperphosphatemia is a late event in the CKDprogression, the effect of phosphorus on PTH, calcitriol and FGF-23 is recognized.Based on observational data, phosphorus dosing during the progression of CKD and inthe dialysis period is suggested, according to Table1. This evidence concerns the gene FGF23 and chronic kidney disease.